Skip to main content

Day: March 17, 2022

Acutus Medical Updates Time and Date of Fourth Quarter and Full Year 2021 Financial Results

CARLSBAD, Calif., March 17, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today updated the planned release of its fourth quarter and full year 2021 financial results to March 30, 2022, as the fiscal year end 2021 audit is not yet complete and is ongoing. There is no disagreement by management with the independent auditors, and the Company fully expects to be in compliance with its SEC filing requirements.    Webcast and Conference Call InformationAcutus will host a conference call to discuss the fourth quarter and full year 2021 financial results after market close on Wednesday, March 30, 2022 at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. The conference call can be accessed...

Continue reading

Chinook Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results

SEATTLE, March 17, 2022 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today provided a business update and reported financial results for the fourth quarter and year ended December 31, 2021. “2021 was a very productive year for Chinook, as we initiated the phase 3 ALIGN and phase 2 AFFINITY trials for atrasentan, presented compelling phase 1/2 data in patients with IgA nephropathy for BION-1301, successfully completed IND-enabling studies for CHK-336, continued to advance multiple programs within our research pipeline and executed notable strategic partnerships including our Evotec research collaboration, formation of Sairopa B.V. for the development of non-renal assets and establishment...

Continue reading

Scilex Holding Company, a Majority-Owned Subsidiary of Sorrento Therapeutics, Inc., to Become Publicly Traded Through a Merger With Vickers Vantage Corp. I

Combined company expected to have a pro forma equity value post-money of approximately $1.64 billion, subject to potential adjustment, and with up to $140 million in expected gross proceeds before expenses, assuming no redemptions from Vickers Vantage Corp. I’s existing public shareholders, which would provide the current stockholders of Scilex an estimated ownership of approximately 88% of the outstanding shares of the Combined Company. Merger expected to close by the third quarter of 2022, and the Combined Company’s common stock is expected to be listed on Nasdaq under the new ticker symbol “SCLX” Funds will be used for, among other things, the potential registration and commercialization of SP-102 (SEMDEXA™) in 2023 and further development of the other existing non-opioid clinical programs for high unmet need acute and chronic pain...

Continue reading

Annual general meeting of Danske Bank 2022

Company announcement no 6 2022  Danske Bank A/SHolmens Kanal 2 – 12DK – 1092 København KTel. +45 45 14 00 00 17 March 2022Annual general meeting of Danske Bank 2022 At the annual general meeting of Danske Bank on Thursday, 17 March 2022, the general meetingadopted the Annual Report 2021 and the proposal for allocation of profits according to the adopted Annual Report 2021 re-elected Martin Blessing, Lars-Erik Brenøe, Raija-Leena Hankonen-Nybom, Bente Avnung Landsnes, Jan Thorsgaard Nielsen, and Carol Sergeant to the Board of Directors. Jacob Dahl, Allan Polack, and Helle Valentin were elected as new members of the Board of Directors, re-appointed Deloitte Statsautoriseret Revisionspartnerselskab as external auditor, adopted the Board of Directors’ proposals to amend the Articles of Association for:extension of the Board...

Continue reading

Verde Bio Holdings, Inc. Discusses Third Quarter Financial Results

FRISCO, TX, March 17, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Verde Bio Holdings, Inc. (OTCQB:VBHI), https://www.verdebh.com/ , a growing oil, gas and alternative energy Company, today filed its 10-Q for the three-month period November 2021 through January 2022.  Mineral and Royalty income totaled $301,567. “This is a significant increase in revenue but less than the Company was expecting.  Verde Bio begins receiving revenue after a transfer process, which  is not in our control.  While we are in pay status on the majority of our properties, some have suspended revenue during this quarter due to consolidations, which causes a month or two delay as accounting is updated,” said Scott Cox, VBHI founder and CEO.  “We can count on receiving back revenues in the current quarter and year-end. “The revenue in our third quarter...

Continue reading

Toll Brothers Announces Groundbreaking at its Toll Brothers at Hosford Farms Community in Portland

Toll Brothers at Hosford Farms Toll Brothers at Hosford Farms, a new luxury home community in Portland, Oregon, announced the groundbreaking of its first collection of homes in the Bethany neighborhood.Toll Brothers at Hosford Farms We have experienced extraordinary demand at Toll Brothers at Hosford Farms, and we are excited to break ground on our first new homes in this incredible community,” said JJ Portlock, Division President of Toll Brothers in Oregon.PORTLAND, Ore., March 17, 2022 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the highly anticipated groundbreaking of its first collection of homes at Toll Brothers at Hosford Farms a new luxury home community in the Bethany neighborhood of Portland, Oregon. As construction begins on the first homes in...

Continue reading

GRUPO AEROMEXICO SUCCESSFULLY COMPLETES FINANCIAL RESTRUCTURING AND EMERGES FROM CHAPTER 11 PROCESS

Mexico, March 17, 2022 (GLOBE NEWSWIRE) — GRUPO AEROMEXICO SUCCESSFULLY COMPLETES FINANCIAL RESTRUCTURING AND EMERGES FROM CHAPTER 11 PROCESS Company emerges from Chapter 11 well-positioned for long-term success. As part of the Court-Approved Joint Plan of Reorganization, the Company equitized recognized unsecured claims (approximately US$2.3 billion) and certain claims under its DIP Facility (approximately US$750 million) obtained during the Chapter 11 Process, and also equitized new equity contributions of more than US$700 million.  Aeromexico will continue serving customers, honoring milestone program, restarting service on certain international routes and opening new routes, while continuing strict protocols to protect the health and safety of employees and customers. Aeromexico continues as Mexico’s flagship airline in...

Continue reading

Nokia Corporation: Repurchase of own shares on 17.03.2022

Nokia CorporationStock Exchange Release17 March 2022 at 21:00 EET Nokia Corporation: Repurchase of own shares on 17.03.2022 Espoo, Finland – On 17 March 2022 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 265,336 4.82CEUX 4,174 4.80AQEU 10,230 4.83TQEX 760 4.81Total 280,500 4.82* Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the current authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in traches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU)...

Continue reading

Results of Eimskip’s 2022 Annual General Meeting

Enclosed are the results of the Annual General Meeting of Eimskipafélag Íslands hf. held today, Thursday 17 March 2022, and updated Articles of Association of the Company. Shareholders presenting 83.56% of the company’s voting share participated in the meeting. The Company will now request the Icelandic Register of Enterprises to grant the Company an exemption from the duty to issue a call to creditors, cf. Article 53.2 of the Act no. 2/1995 respecting Public Limited Companies.AttachmentsEIM_AofA_2022.03.17AGM 2022_Results

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.